FDALiveFDALive.com

The World's Leading Source for FDA Broadcasting

LIVE Services

Webcasting is the most cost-effective way for a single user or a group to view LIVE or archived meetings.

By using internet streaming technology we broadcast from the FDA meeting right to your desktop, to unlimited locations, worldwide. Our cameras focus in on the committee, the presenters and their presentations while sending video and audio live to your desktop. We offer single viewer and group options. If you would like to broadcast a meeting to your group - purchase a multi-viewer "group" license and simply hook up your PC to the internet and project your image on a projector screen while amplifying your audio signal in your conference room.

PRODUCT RATING:

Stream Quality: Very Good

Setup: Easy

Dependability: Very Good

OPTIONS:

Single viewer license (per person - per pc): Allows for a single viewer to view the webcast on their desktop. Cost: $140 - $250

Multi viewer Group license (per person - per pc): Allows for a fullscreen viewing for meeting rooms, auditoriums. Cost: $800 - $1,200

SYSTEM REQUIREMENTS:

Windows PC or MAC with Sound Card/Speakers, Windows Media Player 7 or above and A Broadband Internet Connection.

Upcoming Meetings

Meeting OptionsMeeting OptionsMeeting OptionsMeeting OptionsMeeting OptionsObstetrics and Gynecology Devices Panel

Meeting Date: 2/12/19-2/12/19

.

Meeting Details:

On February 12, 2019, the Committee will discuss and make recommendations regarding the safety and effectiveness of surgical mesh placed transvaginally in the anterior vaginal compartment to treat pelvic organ prolapse. FDA is convening this meeting to seek expert opinion on the evaluation of the risks and benefits of these devices. The Committee will be asked to provide scientific and clinical input on assessing the effectiveness, safety, and benefit/risk of mesh placed transvaginally in the anterior vaginal compartment, as well as identifying the appropriate patient population and physician training needed for these devices.

 

       
Location: Gaithersburg MD Related News Links: Not Available
Time: 8:00AM-6:30PM    
Materials:
   
       

View Meeting Details / News

Recent Meetings

Meeting OptionsMeeting OptionsMeeting OptionsEndocrinologic and Metabolic Drugs AdComm - Sponsor: Sanofi-Aventis US,LLC

Meeting Date: 1/17/19-1/17/19

Meeting Details:

The Committee will discuss new drug application 210934 for sotagliflozin oral tablet, sponsored by Sanofi-Aventis U.S., LLC, for the proposed indication: Adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes mellitus.

 

       
Location: FDA Meeting Room Related News Links: Not Available
Time: 8:00AM-5:00PM    
Materials:
   
       

View Meeting Details / News

Meeting OptionsMeeting OptionsMeeting OptionsBone, Reproductive and Urologic Drugs AdComm - Sponsor: Amgen

Meeting Date: 1/16/19-1/16/19

Meeting Details:

The committee will discuss biologics license application 761062, romosozumab injection, submitted by Amgen, for the proposed indication of treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant of other available osteoporosis therapy.

 

       
Location: FDA Meeting Room Related News Links: Not Available
Time: 8:00AM-5:00PM    
Materials:
   
       

View Meeting Details / News

Meeting OptionsMeeting OptionsMeeting OptionsJoint Arthritis & DSRM AdComm - Sponsor: Takeda Pharmaceuticals

Meeting Date: 1/11/19-1/11/19

Meeting Details:

The committees will discuss supplemental new drug application (sNDA) 021-856, ULORIC (febuxostat) tablets, sponsored by Takeda Pharmaceuticals, which includes the results from the postmarketing safety trial required by FDA to evaluate the cardiovascular safety of febuxostat, entitled “Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES).” Febuxostat is a xanthine oxidase inhibitor indicated for the chronic management of hyperuricemia in patients with gout. The committees' discussion will include the results from the CARES trial, the benefit risk assessment of febuxostat, and potential regulatory actions.

 

       
Location: College Park Marriott Hotel Related News Links: Not Available
Time: 1:00AM-1:00AM    
Materials:
   
       

View Meeting Details / News

Past Meetings

Below is a listing of all committees. Select a committee to display all meetings available for that committee.

Live Meetings

There are no Live Broadcasts available at this time.